Skip to main content
. Author manuscript; available in PMC: 2021 Apr 29.
Published in final edited form as: Curr Opin Endocrinol Diabetes Obes. 2021 Feb 1;28(1):55–63. doi: 10.1097/MED.0000000000000587

Fig 1: BMI SDS/BMI Z score change by weight loss medication.

Fig 1:

A BMI SDS change from representative controlled trials is reported for Orlistat, Metformin, Exenatide, Liraglutide. A BMI Z score change from representative studies is reported for Phentermine, Topiramate.10–14